Chordant Capital is a global lifesciences investment management company. The principal investment objective of the firm is to achieve capital appreciation through investing primarily in publicly traded lifesciences equity securities globally. Chordant employs an experienced team of industry oriented investment professionals to achieve its investment objective. The Chordant team evaluates investments based on in-depth strategic and financial analysis, emphasizing industry fundamentals, competitive position, scientific/medical due diligence and probability weighted expectations implied in securities prices.